Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Stock
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
16.1M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$42.5M
-
Value change
-
-$4.2M
-
Number of buys
-
11
-
Number of sells
-
-22
-
Price
-
$2.65
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q1 2019
52 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q1 2019.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.1M shares
.
Largest 10 shareholders include BB BIOTECH AG (2.3M shares), BVF INC/IL (1.71M shares), Omega Fund Management, LLC (1.51M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Aisling Capital LLC (1.02M shares), Opaleye Management Inc. (1M shares), VANGUARD GROUP INC (966K shares), ALETHEA CAPITAL MANAGEMENT, LLC (564K shares), and Monashee Investment Management LLC (481K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.